Antigen-Specific Treatment Modalities in MS: The Past, the Present, and the Future
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antigen-Specific Treatment Modalities in MS: The Past, the Present, and the Future
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-02-21
DOI
10.3389/fimmu.2021.624685
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial
- (2019) Irati Zubizarreta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Modulation of MS-like disease by a multi epitope protein is mediated by induction of CD11c+CD11b+Gr1+ myeloid-derived dendritic cells
- (2019) N. Kaushansky et al. JOURNAL OF NEUROIMMUNOLOGY
- Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration
- (2019) Barbara Willekens et al. BMJ Open
- Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA
- (2019) Judith Derdelinckx et al. Journal of Neuroinflammation
- Antigen-specific tolerance to self-antigens in protein replacement therapy, gene therapy and autoimmunity
- (2019) Lawrence Steinman et al. CURRENT OPINION IN IMMUNOLOGY
- Gene Therapy-Induced Antigen-Specific Tregs Inhibit Neuro-inflammation and Reverse Disease in a Mouse Model of Multiple Sclerosis
- (2018) Geoffrey D. Keeler et al. MOLECULAR THERAPY
- Effects of ATX-MS-1467 immunotherapy over 16 weeks in relapsing multiple sclerosis
- (2018) Jeremy Chataway et al. NEUROLOGY
- Nanoparticles for the Induction of Antigen-Specific Immunological Tolerance
- (2018) Takashi Kei Kishimoto et al. Frontiers in Immunology
- I’ve got algorithm: predicting tumor and autoimmune peptide targets for CD8+ T cells
- (2016) Devin Dersh et al. JOURNAL OF CLINICAL INVESTIGATION
- Epicutaneous and Oral Low-Zone Tolerance Protects from Colitis in Mice
- (2016) Talkea Schmidt et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Cryopreserved vitamin D3-tolerogenic dendritic cells pulsed with autoantigens as a potential therapy for multiple sclerosis patients
- (2016) María José Mansilla et al. Journal of Neuroinflammation
- The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research
- (2016) Reinhard Hohlfeld et al. LANCET NEUROLOGY
- The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets
- (2016) Reinhard Hohlfeld et al. LANCET NEUROLOGY
- Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide
- (2016) Christoph Buerth et al. PLoS One
- Viral Vectors: The Road to Reducing Genotoxicity
- (2016) Rhiannon M. David et al. TOXICOLOGICAL SCIENCES
- Reprogramming the Local Lymph Node Microenvironment Promotes Tolerance that Is Systemic and Antigen Specific
- (2016) Lisa H. Tostanoski et al. Cell Reports
- Immune modulation by a tolerogenic myelin oligodendrocyte glycoprotein (MOG)10-60 containing fusion protein in the marmoset experimental autoimmune encephalomyelitis model
- (2015) Y. S. Kap et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Properties of myelin altered peptide ligand cyclo(87-99)(Ala91,Ala96)MBP87-99 render it a promising drug lead for immunotherapy of multiple sclerosis
- (2015) George Deraos et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Tolerance of activated pathogenic CD4+ T cells by transcriptional targeting of dendritic cells
- (2015) B de Andrade Pereira et al. GENE THERAPY
- The immunogenetics of multiple sclerosis: A comprehensive review
- (2015) Jill A. Hollenbach et al. JOURNAL OF AUTOIMMUNITY
- Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice
- (2015) Antonella Carambia et al. JOURNAL OF HEPATOLOGY
- Role of the innate and adaptive immune responses in the course of multiple sclerosis
- (2015) Bernhard Hemmer et al. LANCET NEUROLOGY
- Oligodendrocyte death results in immune-mediated CNS demyelination
- (2015) Maria Traka et al. NATURE NEUROSCIENCE
- The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis
- (2015) Giulia Mallucci et al. PROGRESS IN NEUROBIOLOGY
- Co-Delivery of Autoantigen and B7 Pathway Modulators Suppresses Experimental Autoimmune Encephalomyelitis
- (2014) Laura Northrup et al. AAPS Journal
- Beneficial Effect of Tolerogenic Dendritic Cells Pulsed with MOG Autoantigen in Experimental Autoimmune Encephalomyelitis
- (2014) María José Mansilla et al. CNS Neuroscience & Therapeutics
- From classic to spontaneous and humanized models of multiple sclerosis: Impact on understanding pathogenesis and drug development
- (2014) Avraham Ben-Nun et al. JOURNAL OF AUTOIMMUNITY
- Transplantation of Bone Marrow Transduced to Express Self-Antigen Establishes Deletional Tolerance and Permanently Remits Autoimmune Disease
- (2014) J. Chan et al. JOURNAL OF IMMUNOLOGY
- GM-CSF–Neuroantigen Fusion Proteins Reverse Experimental Autoimmune Encephalomyelitis and Mediate Tolerogenic Activity in Adjuvant-Primed Environments: Association with Inflammation-Dependent, Inhibitory Antigen Presentation
- (2014) S. M. Touhidul Islam et al. JOURNAL OF IMMUNOLOGY
- Gene Therapy Delivery of Myelin Oligodendrocyte Glycoprotein (MOG) via Hematopoietic Stem Cell Transfer Induces MOG-Specific B Cell Deletion
- (2014) J.-Y. Chung et al. JOURNAL OF IMMUNOLOGY
- Treatment of Experimental Autoimmune Encephalomyelitis by Codelivery of Disease Associated Peptide and Dexamethasone in Acetalated Dextran Microparticles
- (2014) Kevin J. Peine et al. MOLECULAR PHARMACEUTICS
- The immune epitope database (IEDB) 3.0
- (2014) Randi Vita et al. NUCLEIC ACIDS RESEARCH
- Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance
- (2014) Roberto A. Maldonado et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nanoparticles for the induction of antigen-specific Tregs
- (2013) Francisco J Quintana Immunotherapy
- Targeting of Autoantigens to DEC205+ Dendritic Cells In Vivo Suppresses Experimental Allergic Encephalomyelitis in Mice
- (2013) S. Ring et al. JOURNAL OF IMMUNOLOGY
- Suppression of MOG- and PLP-induced experimental autoimmune encephalomyelitis using a novel multivalent bifunctional peptide inhibitor
- (2013) Ahmed H. Badawi et al. JOURNAL OF NEUROIMMUNOLOGY
- A novel nanoparticle containing MOG peptide with BTLA induces T cell tolerance and prevents multiple sclerosis
- (2013) Bangqing Yuan et al. MOLECULAR IMMUNOLOGY
- Dendritic cells in multiple sclerosis: key players in the immunopathogenesis, key players for new cellular immunotherapies?
- (2013) AH Nuyts et al. Multiple Sclerosis Journal
- Antigen-Specific Tolerance by Autologous Myelin Peptide-Coupled Cells: A Phase 1 Trial in Multiple Sclerosis
- (2013) A. Lutterotti et al. Science Translational Medicine
- Transdermal Application of Myelin Peptides in Multiple Sclerosis Treatment
- (2013) Agata Walczak et al. JAMA Neurology
- Nonmyeloablative Conditioning Generates Autoantigen-Encoding Bone Marrow That Prevents and Cures an Experimental Autoimmune Disease
- (2012) Z. Nasa et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Transcriptional targeting of DCs with lentiviral vectors induces antigen-specific tolerance in a mouse model of multiple sclerosis
- (2012) B de Andrade Pereira et al. GENE THERAPY
- CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery
- (2012) Moa Fransson et al. Journal of Neuroinflammation
- Primary oligodendrocyte death does not elicit anti-CNS immunity
- (2012) Giuseppe Locatelli et al. NATURE NEUROSCIENCE
- T Cell Vaccination Benefits Relapsing Progressive Multiple Sclerosis Patients: A Randomized, Double-Blind Clinical Trial
- (2012) Dimitrios Karussis et al. PLoS One
- Cytokine-Neuroantigen Fusion Proteins as a New Class of Tolerogenic, Therapeutic Vaccines for Treatment of Inflammatory Demyelinating Disease in Rodent Models of Multiple Sclerosis
- (2012) Mark D. Mannie et al. Frontiers in Immunology
- Transplantation of retrovirally transduced bone marrow prevents autoimmune disease in aged mice by peripheral tolerance mechanisms
- (2011) Xiang T. Chen et al. AUTOIMMUNITY
- Neuroantigen-specific, tolerogenic vaccines: GM-CSF is a fusion partner that facilitates tolerance rather than immunity to dominant self-epitopes of myelin in murine models of experimental autoimmune encephalomyelitis (EAE)
- (2011) Derek J Abbott et al. BMC IMMUNOLOGY
- Non-myeloablative transplantation of bone marrow expressing self-antigen establishes peripheral tolerance and completely prevents autoimmunity in mice
- (2011) H Hosseini et al. GENE THERAPY
- Antigen Targeting to Plasmacytoid Dendritic Cells via Siglec-H Inhibits Th Cell-Dependent Autoimmunity
- (2011) J. Loschko et al. JOURNAL OF IMMUNOLOGY
- A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS
- (2011) M. S. Freedman et al. NEUROLOGY
- ‘Multi-Epitope-Targeted’ Immune-Specific Therapy for a Multiple Sclerosis-Like Disease via Engineered Multi-Epitope Protein Is Superior to Peptides
- (2011) Nathali Kaushansky et al. PLoS One
- Immune regulation of multiple sclerosis by transdermally applied myelin peptides
- (2010) Maciej Juryńczyk et al. ANNALS OF NEUROLOGY
- Targeting MOG expression to dendritic cells delays onset of experimental autoimmune disease
- (2010) Hyun-Ja Ko et al. AUTOIMMUNITY
- T cells in multiple sclerosis and experimental autoimmune encephalomyelitis
- (2010) J. M. Fletcher et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Antigen-specific immunotherapy of autoimmune and allergic diseases
- (2010) Catherine A Sabatos-Peyton et al. CURRENT OPINION IN IMMUNOLOGY
- Multiple sclerosis: Distribution of inflammatory cells in newly forming lesions
- (2009) Andrew P. D. Henderson et al. ANNALS OF NEUROLOGY
- Autologous T-Cell Vaccination for Multiple Sclerosis
- (2009) Arthur A Vandenbark et al. BIODRUGS
- Experimental Autoimmune Encephalomyelitis in Lewis rats: IFN- Acts As a Tolerogenic Adjuvant for Induction of Neuroantigen-Dependent Tolerance
- (2009) M. D. Mannie et al. JOURNAL OF IMMUNOLOGY
- A GMCSF-neuroantigen fusion protein is a potent tolerogen in experimental autoimmune encephalomyelitis (EAE) that is associated with efficient targeting of neuroantigen to APC
- (2009) J. L. Blanchfield et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Tolerance Induction in Experimental Autoimmune Encephalomyelitis Using Non-myeloablative Hematopoietic Gene Therapy With Autoantigen
- (2009) Herena Eixarch et al. MOLECULAR THERAPY
- Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis
- (2008) Hideki Garren et al. ANNALS OF NEUROLOGY
- Blood CD8+T cell responses against myelin determinants in multiple sclerosis and healthy individuals
- (2008) Laureline Berthelot et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- GM-CSF in the generation of dendritic cells from human blood monocyte precursors: Recent advances
- (2008) Lucia Conti et al. IMMUNOBIOLOGY
- Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs
- (2008) Stefan Lüth et al. JOURNAL OF CLINICAL INVESTIGATION
- Therapeutic vaccination with a trivalent T-cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis
- (2007) Arthur A. Vandenbark et al. IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started